Tumor treating fields: a new treatment for glioblastoma

被引:3
|
作者
Slavkov, Dimitar [1 ,4 ]
Hadzhiyanev, Asen [2 ]
Slavkova, Svetoslava [3 ]
机构
[1] HELIOS Vogtland Klinikum Plauen GmbH, Clin Neurosurg Spine Surg & Neuromodulat, Plauen, Germany
[2] Med Univ Sofia, Univ Hosp St Ivan Rilsky, Dept Neurosurg, Sofia, Bulgaria
[3] HELIOS Vogtland Klinikum Plauen GmbH, Clin Dermatol, Plauen, Germany
[4] HELIOS Vogtland Klinikum Plauen GmbH, Clin Neurosurg Spine Surg & Neuromodulat, Rontgenstr 2, D-08253 Plauen, Germany
关键词
glioblastoma; therapy; tumor treating fields; TTF; TEMOZOLOMIDE;
D O I
10.1080/13102818.2022.2155567
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Glioblastoma (GBM) is a fatal type of brain tumour. According to the World Health Organization (WHO) classification of 2021, GBMs have WHO grade 4 and are usually associated with a poor prognosis. Since GBMs show a pronounced infiltrative growth, a cure by complete resection of the tumor is unfortunately not possible. Both systemic and locoregional therapy methods are traditionally used and tested to improve the prognosis. A new method that is intended to prolong the progression-free survival is using electromagnetic alternating fields, the so-called tumor treating fields (TTF). This method is based on alternating electrical fields that act on the shaved scalp. The aim is to disrupt cell division and organization of cell organelles. In this review, we discuss the mechanism of TTF, summarize the results of our comprehensive literature search, and discuss potential of this new anti-cancer treatment modality.
引用
收藏
页码:58 / 63
页数:6
相关论文
共 50 条
  • [31] Tumor Treating Fields (TTFields) Therapy and Lomustine Chemotherapy for the Treatment of Unresectable Progressive Glioblastoma
    Mergen, Ertan
    Landrock, Sonja
    Chizzali, Barbara
    CASE REPORTS IN ONCOLOGY, 2024, 17 (01): : 1056 - 1062
  • [32] MITIGATING SKIN IRRITATIONS WITH TUMOR TREATING FIELDS THERAPY IN GLIOBLASTOMA
    Lacouture, Mario
    Iwamoto, Fabio
    Armentano, Francine
    Kim, Esther
    ONCOLOGY NURSING FORUM, 2018, 45 (02)
  • [33] Tumor treating fields increases membrane permeability in glioblastoma cells
    Chang, Edwin
    Patel, Chirag
    Pohling, Christoph
    Young, Caroline
    Song, Jonathan
    Flores, Thomas A.
    Zeng, Yitian
    Joubert, Lydia Marie
    Arami, Hamed
    Natarajan, Arutselvan
    Sinclair, Robert
    Gambhir, Sanjiv S.
    CANCER RESEARCH, 2019, 79 (13)
  • [34] Tumor treating fields increases membrane permeability in glioblastoma cells
    Edwin Chang
    Chirag B. Patel
    Christoph Pohling
    Caroline Young
    Jonathan Song
    Thomas Anthony Flores
    Yitian Zeng
    Lydia-Marie Joubert
    Hamed Arami
    Arutselvan Natarajan
    Robert Sinclair
    Sanjiv S. Gambhir
    Cell Death Discovery, 4
  • [35] Tumor Treating Fields (TTF) with Triple Chemotherapy for Recurrent Glioblastoma
    Zhu, Jay-Jiguang
    Lu, Guangrong
    Rao, Mayank
    Zhu, Ping
    NEUROLOGY, 2017, 88
  • [36] IMPACT OF GENDER ON TUMOR TREATING FIELDS COMPLIANCE IN PATIENTS WITH GLIOBLASTOMA
    Karpf, Lauren
    Chawla, Sanjeev
    Desiderio, Lisa
    Mohan, Suyash
    NEURO-ONCOLOGY, 2020, 22 : 134 - 134
  • [37] Analysis of physical characteristics of Tumor Treating Fields for human glioblastoma
    Lok, Edwin
    San, Pyay
    Hua, Van
    Phung, Melissa
    Wong, Eric T.
    CANCER MEDICINE, 2017, 6 (06): : 1286 - 1300
  • [38] CLINICAL EFFICACY OF TUMOR TREATING FIELDS FOR NEWLY DIAGNOSED GLIOBLASTOMA
    Liu, Yang
    Strawderman, Myla
    Warren, Kwanza
    Richardson, Margie
    Serventi, Jennifer
    Mohile, Nimish
    Milano, Michael
    Walter, Kevin
    NEURO-ONCOLOGY, 2019, 21 : 132 - 132
  • [39] IN SITU DELIVERY OF TUMOR TREATING FIELDS THERAPY IN GLIOBLASTOMA PATIENTS
    Arle, Jeffrey
    Wong, Eric
    Korshoej, Anders
    Dokos, Socrates
    Bomzon, Ze'ev
    Carlson, Kristen
    NEURO-ONCOLOGY, 2019, 21 : 282 - 282
  • [40] Clinical Efficacy of Tumor Treating Fields for Newly Diagnosed Glioblastoma
    Liu, Yang
    Strawderman, Myla S.
    Warren, Kwanza T.
    Richardson, Margie
    Serventi, Jennifer N.
    Mohile, Nimish A.
    Milano, Michael T.
    Walter, Kevin A.
    ANTICANCER RESEARCH, 2020, 40 (10) : 5801 - 5806